泰尼特医疗
THC
267.25
-7.88
-2.86%
泰尼特医疗
US · THC
#905 按市值排名
上市于 1970
267.25
-7.88
-2.86%
实时 - 追踪5344个代码 - 心跳于494秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 机构持股总比例下降了1.1个百分点。
机构持股
- 机构持股比例
- 99.61% -1.14pp
- 机构数量
- 781
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund78.94%
Hedge Fund11.75%
Public Company3.09%
Private Company1.66%
Sovereign Wealth Fund1.52%
Government Pension Fund1.49%
Individual/Insider0.89%
Family Office/Trust0.59%
Insurance Company0.22%
主要股东 截至 2026-06-30
T. Rowe Price Group, Inc.
10.87% · 8.75M 股
BlackRock
10.04% · 8.08M 股
Vanguard Capital Management, LLC
5.51% · 4.44M 股
Boston Partners Global Investors, Inc.
5.51% · 4.43M 股
Vanguard Portfolio Management, LLC
5.26% · 4.24M 股
FMR
4.95% · 3.99M 股
State Street Global Advisors
3.42% · 2.75M 股
Glenview Capital Management, LLC
2.78% · 2.24M 股
Geode Capital Management, LLC
2.34% · 1.88M 股
Citadel Advisors LLC
2.19% · 1.77M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Saumya Sutaria | Chairperson & CEO | 0.54% |
| Michael Maloney | Officer | 0.13% |
| Nadja West | Independent Director | 0.03% |
| James Bierman | Independent Director | 0.03% |
| Tammy Romo | Independent Director | 0.03% |
| Sun Park | Executive Vice President | 0.02% |
| Paola Arbour | Executive Vice President | 0.02% |
| Richard Mark | Independent Director | 0.02% |
| Cecil Haney | Independent Director | 0.02% |
| Meghan FitzGerald | Independent Director | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-13 | Joseph Kerrey | Lead Independent Director | Open Market Disposition | -12,010 | $263.04–264.62 |
| 2026-09-09 | Richard Mark | Independent Director | Open Market Disposition | -10,000 | $263.42 |
| 2026-09-01 | Nadja West | Independent Director | Open Market Disposition | -1,152 | $258.80 |
| 2026-08-30 | Lisa Foo | Executive Vice President of Commercial Operations | Open Market Disposition | -24,000 | $266.32 |
| 2026-08-27 | Cecil Haney | Independent Director | Other Disposition | -150 | -- |
| 2026-08-24 | Saumya Sutaria | Chairperson & CEO | Open Market Disposition | -100,000 | $273.34–278.90 |
| 2026-08-24 | Saumya Sutaria | Chairperson & CEO | Intent to Sell (Form 144) | -50,000 | $274.02 |
| 2026-08-23 | Cecil Haney | Independent Director | Open Market Disposition | -1,300 | $278.03 |
| 2026-08-23 | Saumya Sutaria | Chairperson & CEO | Intent to Sell (Form 144) | -50,000 | $278.70 |
| 2026-08-06 | Tammy Romo | Independent Director | Open Market Disposition | -7,422 | $260.83–264.15 |
| 2026-08-06 | Tammy Romo | Independent Director | Intent to Sell (Form 144) | -2,500 | $260.83 |
| 2026-08-05 | Tammy Romo | Independent Director | Intent to Sell (Form 144) | -4,922 | $264.15 |
| 2026-08-04 | Roy Blunt | Director | Open Market Disposition | -600 | $262.68 |
| 2026-07-28 | Lisa Foo | Executive Vice President of Commercial Operations | Open Market Disposition | -10,000 | $258.03 |
| 2026-07-26 | James Bierman | Independent Director | Open Market Disposition | -5,000 | $244.96 |
| 2026-07-26 | Christopher Lynch | Independent Director | Open Market Disposition | -3,837 | $243.44 |
| 2026-07-26 | Paola Arbour | Executive Vice President | Open Market Disposition | -10,878 | $243.90 |
| 2026-05-27 | Joseph Kerrey | Lead Independent Director | Open Market Disposition | -5,638 | $173.12–177.52 |
| 2026-05-26 | James Bierman | Independent Director | Other Derivative Acquisition | +1,188 | -- |
| 2026-05-26 | Meghan FitzGerald | Independent Director | Other Derivative Acquisition | +1,188 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
泰尼特医疗 讨论区 0 条评论